US Bancorp’s Loxo Oncology, Inc LOXO Stock Holding History

US Bancorp’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-700	Closed	-$99K	–	3745
2018 Q4	$99K	Buy	700 +493	+238%	+$74.8K	﹤0.01%	2129
2018 Q3	$36K	Sell	207 -52	-20%	-$8.74K	﹤0.01%	2717
2018 Q2	$44K	Sell	259 -24	-8%	-$3.61K	﹤0.01%	2645
2018 Q1	$33K	Buy	+283	New	+$30.1K	﹤0.01%	2794

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

US Bancorp's LOXO Position: Q1 2019 in Review

US Bancorp sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 700 shares — an estimated $99K sold.

US Bancorp first reported a position in LOXO in Q1 2018 and held it in 4 quarters. The position peaked at $99K in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

US Bancorp reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
US Bancorp sold 700 Loxo Oncology, Inc shares in Q1 2019, an estimated $99K.
US Bancorp first reported a position in Loxo Oncology, Inc in Q1 2018 and held it in 4 quarters.
US Bancorp's Loxo Oncology, Inc position peaked at $99K in Q4 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on US Bancorp's 13F filing for Q1 2019, filed 8 May 2019.